Apex Kidney Care (AKC), a dialysis service provider, has secured $9 million in Foreign Direct Investment (FDI) from investment vehicles of Blue Earth Capital AG, a Switzerland-based global impact investment firm, for an undisclosed equity stake.
This investment was facilitated by Tata Capital Healthcare Fund (TCHF), the healthcare-focused private equity fund of Tata Capital.
Last year, TCHF invested an equivalent amount in AKC, through a similar equity investment.
“We are delighted to welcome BlueEarth as our Investor Partner. Together with TCHF and BlueEarth, we will continue our mission to expand and strengthen our comprehensive ecosystem for kidney disease patients. BlueEarth’s and TCHF’s confidence in our business ethics and philosophy is a great source of motivation for our team. We remain committed to driving growth by enhancing accessibility, with a strong focus on automation and quality. We will achieve this by collaborating with like-minded clinicians and hospitals, as well as partnering with government through PPP programs,” said Dr Shrirang Bichu, co-founder of Apex Kidney Care.
Rohan Ghose, Director of Private Equity Partnerships at BlueEarth, said, “We are excited about our investment in AKC and the transformative potential it represents. AKC has established itself as a leading provider of high-quality care to dialysis patients, a demographic that often faces significant barriers to accessing sufficient healthcare services. By focusing on semi-urban and rural areas in India, AKC addresses a critical gap in healthcare delivery. What sets AKC apart is its commitment to clinical excellence and patient safety. Through this investment, we are partnering with mission-driven organisation, while creating meaningful social impact by improving access to life-saving dialysis treatment for underserved populations.”
Visalakshi Chandramouli, Managing Partner at Tata Capital Healthcare Fund II said, “We are pleased to partner with Blue Earth Capital, our key Limited Partner, to facilitate a co-investment in a TCHF portfolio company. This collaboration highlights our shared commitment to meeting the growing need for accessible, high-quality dialysis care in India. Co-investments remain a vital part of TCHF’s strategy, providing portfolio companies with enhanced access to growth capital and opportunities.”
Founded in 2008 by leading nephrologists Dr Viswanath Billa, Dr Shrirang Bichu, Dr Jatin Kothari, and Dr Rajesh Kumar, Apex Kidney Care provides comprehensive kidney care at affordable rates to patients suffering from kidney disease. Apex also offers home hemodialysis and other nephrology-related services including kidney transplantation, peritoneal dialysis and nephrology consultations.
Apex currently operates more than 149 centers providing outpatient and inpatient dialysis services across 8 states – Bihar, Delhi, Goa, Gujarat, Karnataka, Madhya Pradesh, Maharashtra, and Rajasthan.
Apex Kidney Care claims to carry out more than 36 thousand dialysis treatments per month with more than 906 modern dialysis machines
